Musculoskeletal abnormalities in velocardiofacial syndrome

Journal of Pediatric Orthopaedics

Volumn 19, Issue 5, 1999, Pages 607-612

  Pollard, Matthew E ^a   Cushing, Michael V ^a   Ogden, John A ^a  

^a ATLANTA MEDICAL CENTER   (United States)

Author keywords

Epiphyseal dysplasia; Orthopaedic; Shprintzen's syndrome; Velocardiofacial syndrome

Indexed keywords

ARTICLE; CASE REPORT; CLEFT PALATE; CLUBFOOT; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC SCREENING; HEARING LOSS; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; KARYOTYPING; MUSCLE HYPOTONIA; MUSCULOSKELETAL SYSTEM MALFORMATION; PRIORITY JOURNAL; SCOLIOSIS; STOMACH FUNDOPLICATION; TRACHEOSTOMY; VELOCARDIOFACIAL SYNDROME;

EID: 0032869065     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01241398-199909000-00010     Document Type: Article

References (15)

1. Amati F, Mari A, Digilio MC, et al. 22q11 deletions in isolated and syndromic patients with tetralogy of Fallot. Hum Genet 1995;95: 479-82.
2. Bonnet D, Cormier-Daire V, Kachaner J, et al. Microstellate DNA markers detect 95% of chromosome 22q11 deletions. Am J Med Genet 1997;68:182-4.
3. Brondum-Nielsen K, Christensen K. Chromosome 22q11 deletion and other chromosome aberrations in cases with cleft palate, congenital heart defects and/or mental disability: a survey based on the Danish Facial Cleft Register. Clin Genet 1996;50:116-20.
4. Devriendt K, De Mars K, De Cock P, Gewillig M, Fryns JP. Terminal deletion in chromosome region 8p23.1 in a child with features of velo-cardio-facial syndrome. Ann Genet 1995;38:228-30.
5. Driscoll DA, Salvin J, Sellinger B, et al. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counseling and prenatal diagnosis. J Med Genet 1993;30:813-7.
6. Goldberg R, Marion R, Borderon M, Wiznia A, Shprintzen RJ. Phenotypic overlap between velo-cardio-facial syndrome (VCF) and the DiGeorge sequence (DGS). Am J Hum Genet 1985;37 (suppl):A54.
7. Kelly D, Goldberg G, Wilson D, et al. Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet 1993;45:308-12.
8. Lachman HM, Morrow B, Shprintzen R, et al. Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 1996;67:468-72.
9. Lipson A, Fagan K, Colley A, et al. Velo-cardio-facial and partial DiGeorge phenotype in a child with interstitial deletion at 10p13: implications for cytogenetics and molecular biology. Am J Med Genet 1996;65:304-8.
10. Lipson A, Yuille D, Angel M, Thompson P, Vandervoord J, Beckenham E. Velocardiofacial (Shprintzen) syndrome: an important syndrome for the dysmorphologist to recognize. J Med Genet 1991;28:596-604.
11. Pierpont JW, Erickson RP, Thompson FH, Yang JM. Size of 22q deletions in four previously reported patients with conotruncal anomaly face syndrome. Clin Genet 1996;50:545-7.
12. Scambler PJ, Carey AH, Wyse RK, et al. Microdeletions within 22q11 associated with sporadic and familial DiGeorge syndrome. Genomics 1991:10:201-6.
13. Shprintzen RJ, Goldberg RB, Lewin ML, Sidoti EJ, Berkman MD, Argamaso RV. A new syndrome involving cleft palate, cardiac anomalies, typical facies, and learning disabilities: velo-cardio-facial syndrome. Cleft Palate J 1978;15:56-62.
14. Sirotkin H, Morrow B, DasGupta R, et al. Isolation of a new clathrin heavy chain gene with muscle-specific expression from the region commonly deleted in velo-cardio-facial syndrome. Hum Mol Genet 1996;5:617-24.
15. Sullivan KE, McDonald-McGinn DM, Driscoll DA, et al. Juvenile rheumatoid arthritis-like polyarthritis in chromosome 22q11.2 deletion syndrome (DiGeorge anomalad / velocardiofacial syndrome / conotruncal anomaly face syndrome). Arthritis Rheum 1997;40: 430-6.